ArticleBone marrow transplantation2026

Clinical outcomes of third-line therapy for aGvHD with gastrointestinal involvement after steroids and ruxolitinib failure.

Johannes Clausen et al.PubMed ↗Publisher ↗

No numbers read from the abstract.